Malaria
📧 Sign up to get email alerts when something new happens for Malaria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Phase I Study of AMA1-C1/Alhydrogel® (Registered Trademark) + CPG 7909 Malaria Vaccine [Phase 1]
Phase I study evaluating AMA1-C1/Alhydrogel with CpG 7909 as a malaria vaccine completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Trial to Determine Safety and Protective Efficacy of Sanaria PfSPZ Challenge With Concurrent Pyrimethamine Treatment That Inhibits Development of Asexual B... [Phase 1]
Phase 1 trial evaluated the safety and protective efficacy of the Sanaria PfSPZ Challenge when given with pyrimethamine chemoprophylaxis to …
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria [Phase 1]
A Phase I trial evaluating the safety and immunogenicity of the AMA1-C1 malaria vaccine formulated with Alhydrogel and CpG 7909; the study h…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Malaria Vaccine for Children in Mali [Phase 1]
A Phase 1 malaria vaccine trial in children in Mali has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Immune Parameters in the Cord Blood of Newborns Exposed to Malaria in the Womb
This entry describes a completed clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) examining imm…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Study of Factors Involved in Resistance to Severe Malaria
This clinical trial update reports a completed study investigating factors involved in resistance to severe malaria.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Examination of Protective Factors Against Severe Malaria
A completed clinical trial examining protective factors against severe malaria, sponsored by the National Institute of Allergy and Infectiou…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Improving the Efficacy of Experimental Malaria Vaccine AMA1-C1/Alhydrogel® (Registered Trademark) [Phase 1]
Phase 1 trial update on the malaria vaccine candidate AMA1-C1 formulated with Alhydrogel. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Severe Malaria and Anti-malarial Drug Resistance in Cambodia
This clinical trial update from NIAID reports completed results related to severe malaria and antimalarial drug resistance in Cambodia.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Medical Implications of Coinfection With Malaria and Filariasis Parasites
A completed clinical trial update from NIAID examining the medical implications of coinfection with malaria and lymphatic filariasis.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Immune Response Regulation in People Infected Concurrently With Malarial and Filarial Parasites
A completed clinical trial by the National Institute of Allergy and Infectious Diseases examining immune response regulation in people co-in…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Estivation of Malaria Vector Mosquitoes in the Sahelian Region of Mali
A completed clinical trial sponsored by the National Institute of Allergy and Infectious Diseases investigated the estivation (seasonal dorm…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Malaria Incidence in Infants in Bancoumana, Mali
This entry reports a completed clinical trial studying malaria incidence and related anemia in infants in Bancoumana, Mali, sponsored by the…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Experimental Vaccine for Malaria [Phase 1]
This update notes the completion of a Phase 1 clinical trial evaluating an experimental malaria vaccine sponsored by NIAID.
-
FDA approval · 2017-06-22FDA Approved: PRIMAQUINE PHOSPHATE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Primaquine Phosphate, approving an update to the product's regulatory status. The product is use…
-
FDA approval · 2017-06-21FDA Approved: PYRIMETHAMINE — Supplemental Application (OAKRUM PHARMA, LLC)
FDA approved a supplemental NDA for Pyrimethamine submitted by Oakrum Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: A Study to Assess the Safety and Immunogenicity of a Malaria Vaccine Candidate, R21, Administered With AS01B [Phase 1]
Phase 1 trial evaluating the safety and immunogenicity of the malaria vaccine candidate R21 with AS01B has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-19Clinical Trial Update: Tafenoquine/Chloroquine DDI Study [Phase 1]
A Phase 1 study evaluating potential drug-drug interactions between tafenoquine and chloroquine in malaria has been completed.
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Tafenoquine Thorough QTc Study in Healthy Subjects [Phase 1]
Phase 1 thorough QTc study of tafenoquine in healthy subjects has been completed to assess potential effects on the QT interval.
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: Safety, Immunogenicity and Efficacy Against of a Combined Malaria Vaccine in Healthy Malaria-naïve Adults [Phase 2]
Phase 2 clinical trial update evaluating safety, immunogenicity, and efficacy of a combined malaria vaccine in healthy malaria-naïve adults;…
-
CLINICAL_TRIALS trial_result · 2017-06-07Clinical Trial Update: G6PD (Glucose-6-phosphate Dehydrogenase) Study to Evaluate Hemolysis Potential of TFQ (Tafenoquine) [Phase 1]
Phase 1 study evaluating the hemolysis risk of tafenoquine (TFQ) in relation to G6PD status. The trial has been completed.
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Field Efficacy Of Insecticide Treated Uniforms And Skin Repellents for Malaria Prevention [Phase 3]
A Phase 3 trial update evaluating the field efficacy of insecticide-treated uniforms and skin repellents for malaria prevention.
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Computerized Cognitive Rehabilitation in Children After Severe Malaria [NA]
A clinical trial evaluating computerized cognitive rehabilitation in children after severe malaria has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis [Phase 1]
Phase 1 trial evaluating immunity conferred by immunization with cryopreserved Plasmodium falciparum sporozoites under chloroquine prophylax…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis [Phase 1]
Phase 1 trial assessing safety and protective efficacy of intravenous immunization with cryopreserved Plasmodium falciparum sporozoites unde…